CBLB and prostate cancer: The genetic deletion or functional inactivation of Cbl-b in NK cells can significantly inhibit the proliferation and metastasis of melanomas [25], and knockout of c-Cbl, a homologue of Cbl-b, can inhibit the proliferation of prostate cancer cells [26].